Effect of long-term preventive treatment with oral rimegepant 75 mg on migraine-related disability: A 52-week, open-label extension studyR. B. Lipton,P. McAllister,I. M. Turner, J. D. Schim, G. J. Litalien, C. M. Jensen, A. C. Thiry, L. Kamen,V Coric, R. CroopHEADACHE（2022）引用 1|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
